Chengdu Kanghong Biotech Co., Ltd.
Establishment time : 2003
website : https://www.kanghong.com/
Main Product : Ophthalmic drugs and medical devices
Company Profile
Chengdu Kanghong Biotech Co., Ltd. is a biopharmaceutical company specializing in the research, development, and commercialization of ophthalmic drugs and medical devices. Established in 2003, the company has grown to become a key player in the global ophthalmology market, with a strong presence in China, Asia-Pacific, Europe, and North America. With a focus on innovation and quality, Kanghong Biotech is dedicated to improving the lives of patients suffering from eye diseases.
Wuhan Institute of Biological Products Co., Ltd.
Establishment time : 1965
website : http://www.wibp.com.cn
Main Product : Vaccines, biological products
Company Profile
Wuhan Institute of Biological Products Co., Ltd. is a renowned company established in 1965, specializing in the production of vaccines and biological products. With a large company size, they have a strong presence in both domestic and international markets, making them a leading manufacturer in the industry. Visit their website for more information.
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
Establishment time : 1997
website : www.baiyunshan.com.cn
Main Product : Pharmaceuticals, health products, medical equipment
Company Profile
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. is a renowned pharmaceutical company in China, specializing in the production and distribution of a wide range of healthcare products. With a history dating back to 1997, the company has grown to become one of the largest in the industry, serving markets in China, Southeast Asia, and Africa. Their commitment to quality and innovation has solidified their position as a key player in the global pharmaceutical market.
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Establishment time : 2003
website : www.yuandapharm.com
Main Product : APIs, intermediates, and finished dosage forms
Company Profile
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. is a leading pharmaceutical company specializing in the production of APIs, intermediates, and finished dosage forms. With a focus on quality and innovation, the company has grown steadily since its establishment in 2003. Serving both domestic and international markets, Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. is committed to providing safe and effective pharmaceutical products to improve global healthcare.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Liaoning Chengda Biotechnology Co., Ltd.
Establishment time : 2005
website : www.chengdabio.com
Main Product : Probiotics, feed additives, veterinary medicines
Company Profile
Liaoning Chengda Biotechnology Co., Ltd. is a leading manufacturer and supplier of probiotics, feed additives, and veterinary medicines. Established in 2005, the company has grown to become a key player in the industry with a strong presence in the domestic market. With a medium-sized operation, Chengda Biotechnology serves customers in China, Southeast Asia, and the Middle East. The company faces competition from international players but continues to innovate and expand its product offerings. Visit www.chengdabio.com for more information.
Changchun Rongsheng Pharmaceutical Co., Ltd.
Establishment time : Changchun Rongsheng Pharmaceutical Co., Ltd. was founded in 2004.
website :
Main Product : It is a medium-sized company operating in the domestic market in China.
Company Profile
With a focus on meeting the needs of its customers, Changchun Rongsheng Pharmaceutical Co., Ltd. aims to become a leading player in the pharmaceutical industry in China.
June 26, 2024
